These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 25803367)

  • 1. Statistics Commentary Series: Commentary #10-Dealing With Drop-Outs.
    Streiner DL
    J Clin Psychopharmacol; 2015 Oct; 35(5):496-8. PubMed ID: 25803367
    [No Abstract]   [Full Text] [Related]  

  • 2. A systematic review finds variable use of the intention-to-treat principle in musculoskeletal randomized controlled trials with missing data.
    Joseph R; Sim J; Ogollah R; Lewis M
    J Clin Epidemiol; 2015 Jan; 68(1):15-24. PubMed ID: 25304501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Missing data handling in chronic pain trials.
    Kim Y
    J Biopharm Stat; 2011 Mar; 21(2):311-25. PubMed ID: 21391004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary imputation methods impact efficacy results in hidradenitis suppurativa clinical trials.
    Frew JW
    J Am Acad Dermatol; 2020 Aug; 83(2):663-665. PubMed ID: 32247874
    [No Abstract]   [Full Text] [Related]  

  • 5. Addressing missing participant outcome data in dental clinical trials.
    Spineli LM; Fleming PS; Pandis N
    J Dent; 2015 Jun; 43(6):605-18. PubMed ID: 25837533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intent-to-treat analysis for longitudinal studies with drop-outs.
    Little R; Yau L
    Biometrics; 1996 Dec; 52(4):1324-33. PubMed ID: 8962456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dropouts and missing data in psychiatric clinical trials.
    Potkin SG; Siu CO
    Am J Psychiatry; 2009 Nov; 166(11):1295; author reply 1295-6. PubMed ID: 19884237
    [No Abstract]   [Full Text] [Related]  

  • 8. Statistics commentary series: Commentary #5--can it work or does it work? The difference between efficacy and effectiveness trials.
    Streiner DL
    J Clin Psychopharmacol; 2014 Dec; 34(6):672-4. PubMed ID: 25275674
    [No Abstract]   [Full Text] [Related]  

  • 9. Partial imputation approach to analysis of repeated measurements with dependent drop-outs.
    Wei L; Shih WJ
    Stat Med; 2001 Apr; 20(8):1197-214. PubMed ID: 11304736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intention-to-treat in randomized controlled trials: recommendations for a total trial strategy.
    Polit DF; Gillespie BM
    Res Nurs Health; 2010 Aug; 33(4):355-68. PubMed ID: 20645423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Bayesian framework for intent-to-treat analysis with missing data.
    Kleinman KP; Ibrahim JG; Laird NM
    Biometrics; 1998 Mar; 54(1):265-78. PubMed ID: 9544521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of intention to treat in analysis of noninferiority studies.
    Wiens BL; Zhao W
    Clin Trials; 2007; 4(3):286-91. PubMed ID: 17715258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistics Commentary Series. Commentary No. 43: Patient Preference Trials.
    Streiner DL
    J Clin Psychopharmacol; 2020; 40(6):529-530. PubMed ID: 33044357
    [No Abstract]   [Full Text] [Related]  

  • 14. Intention to treat analysis: how frequently is it used in ENT randomised controlled trials?
    Achar P; Mitra I; Duvvi S; Kumar BN
    Clin Otolaryngol; 2010 Feb; 35(1):65-7. PubMed ID: 20447170
    [No Abstract]   [Full Text] [Related]  

  • 15. Sensitivity analysis of longitudinal normal data with drop-outs.
    Minini P; Chavance M
    Stat Med; 2004 Apr; 23(7):1039-54. PubMed ID: 15057877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Describing the participants in a study.
    Pickering RM
    Age Ageing; 2017 Jul; 46(4):576-581. PubMed ID: 28472376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistics Commentary Series. Commentary No. 41: Randomization.
    Streiner DL
    J Clin Psychopharmacol; 2020; 40(5):439-440. PubMed ID: 32773494
    [No Abstract]   [Full Text] [Related]  

  • 18. Statistics Commentary Series. Commentary No. 42: Minimization.
    Streiner DL
    J Clin Psychopharmacol; 2020; 40(5):441-442. PubMed ID: 32701908
    [No Abstract]   [Full Text] [Related]  

  • 19. Statistics Commentary Series. Commentary No. 44: Internal and External Validity.
    Streiner DL
    J Clin Psychopharmacol; 2020; 40(6):531-533. PubMed ID: 33044353
    [No Abstract]   [Full Text] [Related]  

  • 20. Intention-to-treat analyses for incomplete repeated measures data.
    Hogan JW; Laird NM
    Biometrics; 1996 Sep; 52(3):1002-17. PubMed ID: 8805765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.